# ECO Animal Health Group plc receives marketing authorisation for Aivlosin® in chickens laying eggs for human consumption.

- Link: https://www.directorstalkinterviews.com/eco-animal-health-group-plc-receives-marketing-authorisation-for-aivlosin-in-chickens-laying-eggs-for-human-consumption/412768551
- Published: 2019-03-05T07:31:18+00:00
- Author: Giles Arbor

**ECO Animal Health Group plc** (LON: EAH) has today announced that its subsidiary
ECO Animal Health Limited (ECO) has received a marketing authorisation from the 
Central Drugs Standard Control Organisation, Ministry of Health & Family Welfare
of the Government of India for the use of Aivlosin® 625 mg/g water soluble granules
in chickens laying eggs for human consumption.

This approval allows ECO to start selling Aivlosin® in India for the medication 
of drinking water for the treatment of infections caused by Mycoplasma in poultry
laying eggs for human consumption, with a zero day drug withdrawal period for eggs.

Aivlosin®, ECO’s patented antimicrobial, is used under veterinary prescription for
the treatment of a variety of economically important respiratory and enteric (gut)
diseases in poultry and pigs.

> **Peter Lawrence, Non-Executive Chairman of ECO Animal Health Group plc, commented**
> “India is ranked second with just over 5 per cent of the world’s laying birds 
> and although the market is somewhat fragmented, we expect this to change in the
> future. This latest approval demonstrates ECO’s continued progress in rolling 
> out this indication for commercial layers.”

Share on: